[Rapid-eye-movement sleep disorders in Parkinson's disease]
- PMID: 11965170
[Rapid-eye-movement sleep disorders in Parkinson's disease]
Abstract
During the past 10 years, there has been an increasing interest in the study of rapid-eye-movement (REM) sleep in neurodegenerative diseases and more particulary in Parkinson's disease (PD). This interest is justified by the strong association observed between these diseases and REM sleep behavior disorder (RBD). In the first section of this paper, a critical review of the literature on the presence of REM sleep disorders in PD is presented. Studies that show an association between PD and RBD are reviewed. Studies that report the presence of other REM sleep disorders in PD (short latency, abnormal length and/or proportion of REM sleep, increasing occurrence of hallucinations) are then discussed. Limitations of the criteria proposed by Rechtschaffen et Kales (1968) for the quantification of REM sleep are also presented. Some authors believe that dopaminergic (DA) agents used in the treatment of PD (levodopa, bromocriptine, pergolide, pramipexole and selegiline) could be a responsable factor for the occurence of REM sleep disorders observed in this disease. The literature concerning the impact of these DA agents on human REM sleep is therefore critically reviewed. It is concluded that DA agents cannot explain on their own the presence of REM sleep disorders in PD. Other causes, among which the disturbance of some neurochemical systems linked to the neuropathological process of the disease, must be considered in order to explain these REM sleep disorders. In the second section of this paper, we present the different pathophysiological hypotheses proposed to explain REM sleep disorders in PD, such as a dysfunction of the cholinergic, noradrenergic, serotonergic, dopaminergic or GABAergic neurons. Emphasis is placed on the role of cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei, structures shown to be particularly impaired in PD. Neurophysiological, neuroanatomical and neuropharmacological studies demonstrate that these neurons are strongly implicated in the different REM sleep parameters (muscular atonia, electroencephalographic desynchronisation, ponto-geniculo-occipital spikes). Finally, future research directions are proposed.
Similar articles
-
[Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].Glas Srp Akad Nauka Med. 2011;(51):85-97. Glas Srp Akad Nauka Med. 2011. PMID: 22165729 Review. Serbian.
-
Decreased phasic EMG activity during rapid eye movement sleep in treatment-naïve Parkinson's disease: effects of treatment with levodopa and progression of illness.Mov Disord. 2002 Sep;17(5):934-41. doi: 10.1002/mds.10233. Mov Disord. 2002. PMID: 12360542
-
Rapid eye movement sleep behavior disorder.Ann Pharmacother. 2007 Nov;41(11):1833-41. doi: 10.1345/aph.1H587. Epub 2007 Oct 9. Ann Pharmacother. 2007. PMID: 17925503 Review.
-
Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa.Mov Disord. 1996 Mar;11(2):214-6. doi: 10.1002/mds.870110216. Mov Disord. 1996. PMID: 8684394
-
Polysomnographic measures in Parkinson's disease: a comparison between patients with and without REM sleep disturbances.Wien Klin Wochenschr. 2001 Apr 17;113(7-8):249-53. Wien Klin Wochenschr. 2001. PMID: 11383385
Cited by
-
Changes in the neuronal activity in the pedunculopontine nucleus in chronic MPTP-treated primates: an in situ hybridization study of cytochrome oxidase subunit I, choline acetyl transferase and substance P mRNA expression.J Neural Transm (Vienna). 2007 Mar;114(3):319-26. doi: 10.1007/s00702-006-0547-x. Epub 2006 Sep 21. J Neural Transm (Vienna). 2007. PMID: 16988796
-
Functional evaluation of central cholinergic circuits in patients with Parkinson's disease and REM sleep behavior disorder: a TMS study.J Neural Transm (Vienna). 2013 Mar;120(3):413-22. doi: 10.1007/s00702-012-0888-6. Epub 2012 Aug 19. J Neural Transm (Vienna). 2013. PMID: 22903350
-
Rapid Eye Movement Sleep Deprivation Associated Increase in Na-K ATPase Activity in the Rat Brain is Due to Noradrenaline Induced α1-Adrenoceptor Mediated Increased α-Subunit of the Enzyme.Neurochem Res. 2015 Aug;40(8):1747-57. doi: 10.1007/s11064-015-1660-8. Epub 2015 Jul 7. Neurochem Res. 2015. PMID: 26148532
-
The phonation test can distinguish the patient with Parkinson's disease via Bayes inference.Cogn Neurodyn. 2025 Dec;19(1):18. doi: 10.1007/s11571-024-10194-x. Epub 2025 Jan 9. Cogn Neurodyn. 2025. PMID: 39801919
-
The Role of Inflammation in Cognitive Impairment of Obstructive Sleep Apnea Syndrome.Brain Sci. 2022 Sep 27;12(10):1303. doi: 10.3390/brainsci12101303. Brain Sci. 2022. PMID: 36291237 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous